Stock Information
Erasca Inc (ERAS)
Ticker Symbol: ERAS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,874.93 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.4506
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -33.1%
Latest News
-
Guggenheim Maintains Buy on Erasca, Raises Price Target to $20
Mon, Mar 16, 2026 8:50 AM
-
Piper Sandler Maintains Overweight on Erasca, Raises Price Target to $18
Fri, Mar 13, 2026 12:41 PM
-
Mizuho Maintains Outperform on Erasca, Raises Price Target to $19
Fri, Mar 13, 2026 9:28 AM
-
FTAI Aviation To Rally More Than 43%? Here Are 10 Top Analyst Forecasts For Friday
Fri, Mar 13, 2026 8:09 AM
-
HC Wainwright & Co. Maintains Buy on Erasca, Raises Price Target to $20
Fri, Mar 13, 2026 7:15 AM
-
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Thu, Mar 12, 2026 8:01 PM
-
Erasca Q4 EPS $(0.10), Inline
Thu, Mar 12, 2026 4:08 PM
Key Financials
Financial data not available